Status:

COMPLETED

SAHaRA: A Randomized Controlled Trial

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

Conditions:

Subarachnoid Hemorrhage, Aneurysmal

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes...

Detailed Description

We hypothesize that in adult patients suffering from aSAH and anemia, a liberal RBC transfusion strategy as compared to a restrictive RBC transfusion strategy decreases the combined rate of death and ...

Eligibility Criteria

Inclusion

  • Age ≥18 years old at time of SAH
  • First ever episode of aneurysmal SAH
  • Diagnosis of aSAH as confirmed by treating physician (eg: neurosurgeon or neuro- interventionalist) and supported by blood in subarachnoid space (e.g. cranial imaging or cerebrospinal fluid positive for xanthochromia, surgical visualization) that is the result of a ruptured aneurysm (e.g. direct visualization, cranial imaging or catheter angiogram)
  • Hb ≤100g/L within 10 days following aSAH (defined by first day of hospital presentation)

Exclusion

  • Physician and or family decision to withdraw/withhold active medical care at time of enrolment
  • Active bleeding with hemodynamic instability at time of enrolment
  • Patients with contraindication or known objection to blood transfusions
  • SAH due to mycotic aneurysm, infundibulum and vascular malformations.

Key Trial Info

Start Date :

February 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 22 2024

Estimated Enrollment :

742 Patients enrolled

Trial Details

Trial ID

NCT03309579

Start Date

February 12 2018

End Date

August 22 2024

Last Update

November 6 2024

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

University of Colorado School of Medicine

Aurora, Colorado, United States, 80045

2

Emory University School of Medicine

Atlanta, Georgia, United States, 30322

3

Rush University Medical Center

Chicago, Illinois, United States, 60612

4

Nepean Hospital

Kingswood, New South Wales, Australia

SAHaRA: A Randomized Controlled Trial | DecenTrialz